Works matching AU Hellmann, Mark A.

Results: 25

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.

Published in:

JAMA Neurology, 2022, v. 79, n. 5, p. 518, doi. 10.1001/jamaneurol.2022.0489

By:

Chen, John J.;
Huda, Saif;
Hacohen, Yael;
Levy, Michael;
Lotan, Itay;
Wilf-Yarkoni, Adi;
Stiebel-Kalish, Hadas;
Hellmann, Mark A.;
Sotirchos, Elias S.;
Henderson, Amanda D.;
Pittock, Sean J.;
Bhatti, M. Tariq;
Eggenberger, Eric R.;
Di Nome, Marie;
Kim, Ho Jin;
Kim, Su-Hyun;
Saiz, Albert;
Paul, Friedemann;
Dale, Russell C.;
Ramanathan, Sudarshini

Publication type:

Article

Incidence of AChR Ab‐positive myasthenia gravis in Israel: A population‐based study.

Published in:

Acta Neurologica Scandinavica, 2020, v. 142, n. 1, p. 66, doi. 10.1111/ane.13239

By:

Lotan, Itay;
Benninger, Felix;
Hellmann, Mark A.;
Sicsic, Camille;
Brenner, Talma;
Kahana, Ester;
Steiner, Israel

Publication type:

Article

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.

Published in:

PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0288366

By:

Wilf-Yarkoni, Adi;
Feldmann, Kristina;
Rubarth, Kerstin;
Dorsch, Eva-Maria;
Rust, Rebekka;
Urman, Ilia;
Hellmann, Mark A.;
Friedman, Yitzhak;
Lotan, Itay;
Bialer, Omer;
Buenrostro, Gilberto Solorza;
Zimmermann, Hanna G.;
Leutloff, Carla;
Schmitz-Hübsch, Tanja;
Paul, Friedemann;
Asseyer, Susanna;
Stiebel-Kalish, Hadas

Publication type:

Article

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.868915

By:

Milo, Ron;
Staun-Ram, Elsebeth;
Karussis, Dimitrios;
Karni, Arnon;
Hellmann, Mark A.;
Bar-Haim, Erez;
Miller, Ariel;
Glass-Marmor, Lea;
Volkovitz, Anat;
Dishon, Sara;
Dishon, Zeev;
Kugelman, Netta;
Nitsan, Zeev;
Alkrenawi, Marwan;
Hovel, Nurit;
Michal, Nir;
Loew-Shavit, Vered;
Mizrahi, Lital;
Zafrani, Marsel;
Petrou, Panayiota

Publication type:

Article

Automotive Fuel Cell Systems: Testing Highly Dynamic Scenarios.

Published in:

Energies (19961073), 2023, v. 16, n. 2, p. 664, doi. 10.3390/en16020664

By:

Breitinger, Jonas;
Hellmann, Mark;
Kemmer, Helerson;
Kabelac, Stephan

Publication type:

Article

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.

Published in:

PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170847

By:

Stiebel-Kalish, Hadas;
Lotan, Itay;
Brody, Judith;
Chodick, Gabriel;
Bialer, Omer;
Marignier, Romain;
Bach, Michael;
Hellmann, Mark Andrew

Publication type:

Article

The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI.

Published in:

Brain & Behavior, 2024, v. 14, n. 7, p. 1, doi. 10.1002/brb3.3587

By:

Ganelin‐Cohen, Esther;
Buxbaum, Chen;
Bosak, Noam;
Sobol, Shani;
Vaknin‐Dembinsky, Adi;
Hellmann, Mark A;
Wilf‐Yarkoni, Adi;
Regev, Keren;
Pustovoyt, Elizaveta;
Shifrin, Alla;
Wexler, Yair;
Rozenberg, Ayal

Publication type:

Article

Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Published in:

2021

By:

Lotan, Itay;
Hellmann, Mark A.;
Wilf-Yarkoni, Adi;
Steiner, Israel

Publication type:

Literature Review

Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis.

Published in:

Journal of Neurology, 2021, v. 268, n. 10, p. 3871, doi. 10.1007/s00415-021-10544-3

By:

Wilf-Yarkoni, Adi;
Lotan, Itay;
Steiner, Israel;
Hellmann, Mark A.

Publication type:

Article

Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.

Published in:

Journal of Neurology, 2018, v. 265, n. 9, p. 1985, doi. 10.1007/s00415-018-8956-y

By:

Lotan, Itay;
Brody, Judith;
Hellmann, Mark Andrew;
Bialer, Omer;
Ganelin-Cohen, Esther;
Michaeli, Natalia;
Marignier, Romain;
Stiebel-Kalish, Hadas

Publication type:

Article

Frequent misdiagnosis of adult polyglucosan body disease.

Published in:

Journal of Neurology, 2015, v. 262, n. 10, p. 2346, doi. 10.1007/s00415-015-7859-4

By:

Hellmann, Mark;
Kakhlon, Or;
Landau, Ezekiel;
Sadeh, Menachem;
Giladi, Nir;
Schlesinger, Ilana;
Kidron, Daphne;
Abramsky, Oded;
Reches, Avinoam;
Argov, Zohar;
Rabey, Jose;
Chapman, Joab;
Rosenmann, Hanna;
Gal, Aya;
Moshe Gomori, J.;
Meiner, Vardiella;
Lossos, Alexander

Publication type:

Article

Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease.

Published in:

Movement Disorders, 2010, v. 25, n. 7, p. 924, doi. 10.1002/mds.23030

By:

Hellmann, Mark A.;
Melamed, Eldad;
Steinmetz, Adam P.;
Djaldetti, Ruth

Publication type:

Article

Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease.

Published in:

Movement Disorders, 2006, v. 21, n. 11, p. 2008, doi. 10.1002/mds.21090

By:

Hellmann, Mark A.;
Djaldetti, Ruth;
Israel, Zvi;
Melamed, Eldad

Publication type:

Article

[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.

Published in:

Movement Disorders, 2006, v. 21, n. 4, p. 510, doi. 10.1002/mds.20748

By:

Lorberboym, Mordechai;
Treves, Therese A.;
Melamed, Eldad;
Lampl, Yair;
Hellmann, Mark;
Djaldetti, Ruth

Publication type:

Article

Bent knees and tiptoeing: Late manifestations of end-stage Parkinson's disease.

Published in:

Movement Disorders, 2004, v. 19, n. 11, p. 1325, doi. 10.1002/mds.20187

By:

Djaldetti, Ruth;
Hellmann, Mark;
Melamed, Eldad

Publication type:

Article

Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease.

Published in:

Movement Disorders, 2002, v. 17, n. 5, p. 1097, doi. 10.1002/mds.10232

By:

Hellmann, Mark A.;
Melamed, Eldad

Publication type:

Article

Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli Cohort.

Published in:

Israel Medical Association Journal, 2024, v. 26, n. 7/8, p. 434

By:

Fineberg, Aviv;
Lotan, ltay;
Bialer, Omer;
Tiosano, Alon;
Rozenblatt, Shira;
Wilf-Yarkoni, Adi;
Hellmann, Mark A.;
Stiebel-Kalish, Hadas

Publication type:

Article

Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network.

Published in:

Annals of Clinical & Translational Neurology, 2024, v. 11, n. 9, p. 2473, doi. 10.1002/acn3.52166

By:

Klyscz, Philipp;
Asseyer, Susanna;
Alonso, Ricardo;
Bereuter, Charlotte;
Bialer, Omer;
Bick, Atira;
Carta, Sara;
Chen, John J.;
Cohen, Leila;
Cohen‐Tayar, Yamit;
Carnero Contentti, Edgar;
Dale, Russell C.;
Flanagan, Eoin P.;
Gernert, Jonathan A.;
Haas, Julian;
Havla, Joachim;
Heesen, Christoph;
Hellmann, Mark;
Levin, Netta;
Lopez, Pablo

Publication type:

Article

Alemtuzumab mediates the CD39+ T‐regulatory cell response via CD23+ macrophages.

Published in:

Immunology & Cell Biology, 2021, v. 99, n. 5, p. 521, doi. 10.1111/imcb.12431

By:

Remez, Lital;
Ganelin‐Cohen, Esther;
Safina, Dina;
Hellmann, Mark A;
Lotan, Itay;
Bosak, Noam;
Buxbaum, Chen;
Vaknin, Adi;
Shifrin, Alla;
Rozenberg, Ayal

Publication type:

Article

Prior damage to lower motor neuron triggering myasthenia gravis.

Published in:

2016

By:

Steiner, Israel;
Goldstein, Lilach;
Hellmann, Mark A.;
Lotan, Itay

Publication type:

journal article

(DMT21) Glatiramer Acetate Depot (Extended Release) Phase 2a Study in Patients With Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot.

Published in:

International Journal of MS Care, 2024, v. 26, p. 33

By:

Flechter, Shlomo;
Miller, Aaron E.;
Popper, Laura;
Almog, Ornit;
Kimelman, Nadav Bleich;
Rubnov, Shai;
Danon, Uri;
Marom, Ehud;
Milo, Ron;
Eilam, Anda;
Vaknin-Dembinsky, Adi;
Hellmann, Mark;
Shifrin, Alla;
Karni, Arnon

Publication type:

Article

Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.

Published in:

2023

By:

Stiebel-Kalish, Hadas;
Rubarth, Kerstin;
Shouchane-Blum, Karny;
Tiosano, Alon;
Lotan, Itay;
Hellmann, Mark A.;
Wilf-Yarkoni, Adi;
Bialer, Omer;
Flanagan, Eoin P.;
Pittock, Sean J.;
Bhatti, M. Tariq;
Schmitz-Hübsch, Tanja;
Paul, Friedemann;
Asseyer, Susanna;
Chen, John J.

Publication type:

Correction Notice

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21592-8

By:

Stiebel-Kalish, Hadas;
Rubarth, Kerstin;
Shouchane-Blum, Karny;
Tiosano, Alon;
Lotan, Itay;
Hellmann, Mark A.;
Wilf-Yarkoni, Adi;
Bialer, Omer;
Flanagan, Eoin P.;
Pittock, Sean J.;
Bhatti, M. Tariq;
Schmitz-Hübsch, Tanja;
Friedemann, Paul;
Asseyer, Susanna;
Chen, John J.

Publication type:

Article

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.

Published in:

Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1080, doi. 10.1177/13524585231184738

By:

Lotan, Itay;
Chen, John J;
Hacohen, Yael;
Abdel-Mannan, Omar;
Mariotto, Sara;
Huda, Saif;
Gibbons, Emily;
Wilf-Yarkoni, Adi;
Hellmann, Mark A;
Stiebel-Kalish, Hadas;
Pittock, Sean J;
Flanagan, Eoin P;
Molazadeh, Negar;
Anderson, Monique;
Salky, Rebecca;
Romanow, Gabriela;
Schindler, Patrick;
Duchow, Ankelien Solveig;
Paul, Friedemann;
Levy, Michael

Publication type:

Article

Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.

Published in:

European Journal of Neurology, 2021, v. 28, n. 11, p. 3742, doi. 10.1111/ene.15028

By:

Lotan, Itay;
Wilf‐Yarkoni, Adi;
Friedman, Yitzhak;
Stiebel‐Kalish, Hadas;
Steiner, Israel;
Hellmann, Mark A.

Publication type:

Article

Works matching AU Hellmann, Mark A.

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.

Incidence of AChR Ab‐positive myasthenia gravis in Israel: A population‐based study.

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.

Automotive Fuel Cell Systems: Testing Highly Dynamic Scenarios.

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.

The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI.

Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis.

Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.

Frequent misdiagnosis of adult polyglucosan body disease.

Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease.

Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease.

[<sup>123</sup>I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.

Bent knees and tiptoeing: Late manifestations of end-stage Parkinson's disease.

Focal dystonia as the presenting sign in Creutzfeldt-Jakob disease.

Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli Cohort.

Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network.

Alemtuzumab mediates the CD39<sup>+</sup> T‐regulatory cell response via CD23<sup>+</sup> macrophages.

Prior damage to lower motor neuron triggering myasthenia gravis.

(DMT21) Glatiramer Acetate Depot (Extended Release) Phase 2a Study in Patients With Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot.

Author Correction: Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.

Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.